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  SPECTROPHOTOMETRIC DETERMINATION 
OF REPAGLINIDE IN TABLETS BASED ON 
CHARGE-TRANSFER COMPLEXATION 
REACTION WITH CHLORANILIC ACID AND 
DICHLORO-DICYANO BENZOQUINONE 
Two simple, accurate, precise, inexpensive, selective and sensitive spectro-
photometric methods are described for the determination of repaglinide (RPG) 
in bulk drug and its tablets. The methods were based on the charge- transfer 
complex reaction between RPG in acetonitrile with p-chloranilic acid (CAA) or 
2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) in dioxane and subsequent 
formation of intensely colored radical anions of the reagents which were  mea-
sured at 520 (CAA) or 590 nm (DDQ). Several experimental variables affecting 
the complex formation, stability of the colored species and sensitivity of the re-
action were optimized. Under the optimized conditions, Beer’s law was obeyed 
over the concentration ranges of 20-400 and 5-80 μg ml-1 RPG for CAA and 
DDQ methods, respectively, and the corresponding correlation coefficients 
were 0.9995 and 0.9998. The apparent molar absorptivity values were 
1.02×103 and 4.60×103 for CAA and DDQ methods, respectively, with corres-
ponding Sandell sensitivity values of 0.4438 and 0.0984 μg cm-2. Limits of de-
tection (LOD) were calculated to be 7.07 and 2.42 μg ml-1 and the limits of 
quantification (LOQ) were 21.43 and 7.33 μg ml-1 RPG, for CAA and DDQ me-
thods, respectively. Validation results demonstrated that the inter day and intra 
day accuracy were up to 97.56%. The precision determined did not exceed 
2.5% of RSD. The methods were successfully used for the determination of 
RPG in tablet form and the results were in good agreement with the label 
claims as shown by the recoveries which were in the range of 99.22-102.8% 
with standard deviation values <2%. The accuracy of the methods was con-
firmed by recovery studies via standard-addition procedure with excellent re-
covery 98.24-104.0±1.08-3.35. 
Keywords: repaglinide; p-chloranilic acid; 2,3-dichloro-5,6-dicyano-1,4-
-benzoquinone; charge transfer complexation; pharmaceuticals. 
 
 
Repaglinide (RPG), chemically known as (S)- 
-(+)-2-ethoxy-4-[2-(3-methyl-1-[2-(piperidin-1-yl)phenyl]-
butylamino)-2-oxoethyl] benzoic acid is a new car-
boxy methyl benzoic acid derivative. It is a novel pra-
ndial glucose regulator for the treatment type-2 dia-
betes mellitus [1,2]. It reduces the fasting glucose 
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concentration in patients with type-2 diabetes melli-
tus. It helps to control blood glucose sugar by in-
creasing the amount of insulin released by the pan-
creas. RPG is rapidly absorbed from the gastrointes-
tinal tract after oral administration. It differs from other 
antidiabetic agents in its structure, binding profile, du-
ration of action and mode of extraction [3]. The drug is 
official in both European Pharmacopoeia [4], which 
describes non-aqueous titrimetry for its assay, and 
United State Pharmacopoeia [5] which recommends 
HPLC method for RPG determination. From the litera-
ture survey, it is revealed that a very few methods 
have been reported for the determination of RPG in 
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pure form and dosage form; and include high perfor-
mance liquid chromatography [6-8], reversed phase 
thin layer chromatography [9], spectrofluorimetry [8], 
voltammetry [10], UV-spectrophotometry [11-14] and 
visible spectrophotometry [14-16].  
To the best of our knowledge, there are three 
reports on the use of visible spectrophotometry for the 
determination of RPG in pharmaceuticals [14-16], but 
all three reports are based on the formation of extract-
able ion association complex with different dyes. How-
ever, many of the above methods suffered from one 
or other disadvantage like poor sensitivity, measure-
ments done at shorter wavelengths, extraction step, 
rigid pH control and use of expensive chemical and/or 
complicated experimental setup. 
In this paper, the development and validation of 
two simple, sensitive, selective and rapid visible spec-
trophotometric methods are presented. The deve-
loped methods were based on the formation of in-
tensely colored species resulting from the charge- 
transfer complex formed between RPG acting as an 
n-donor and CAA or DDQ acting as π-acceptor. These 
π-acceptors have numerous applications as analytical 
reagents and they have been used for the spectro-
photometric determination of many organic com-
pounds of pharmaceutical interest [17-21]. The deve-
loped methods were validated for linear range, LOD 
and LOQ, accuracy and precision and robustness and 
ruggedness. The validated methods were applied to 
commercially available tablets containing RPG with 
acceptable accuracy and precision. 
EXPERIMENTAL 
Apparatus 
A Systronics model 106 digital spectrophoto-
meter with 1 cm path length matched quartz cells was 
used for the absorbance measurement. 
Materials and reagents 
Pure active ingredient sample of RPG was 
kindly supplied by Torrent Pharmaceuticals Ltd., Ah-
madabad, India, as a gift. Eurepa-1 (1 mg RPG) and 
Eurepa-2 (2 mg RPG) tablets, marketed by Torrent 
Pharmaceuticals, Ahmadabad, India, were purchased 
from local commercial sources.  
All chemicals used were of analytical reagent 
grade. Spectroscopic grade acetonitrile (Merck, Mum-
bai, India) was used to prepare RPG in both the me-
thods while 1,4-dioxane (Merck, Mumbai, India) was 
used to prepare DDQ (Avra Synthesis Pvt. Ltd., Hy-
derabad, India) and CAA (Rolex Laboratory Reagent, 
Mumbai, India). A 0.2% (w/v) solution each of CAA 
and DDQ was prepared freshly and separately by 
dissolving 0.2 g of each reagent in 100 ml of 1,4-di-
oxane. 
Standard RPG stock solution 
A 500 µg ml-1 RPG stock solution was prepared 
by dissolving 50 mg of pure drug in acetonitrile in a 
100 ml volumetric flask and the solution was diluted to 
the mark with the same solvent and used for CAA 
method. The stock solution was diluted to get 100 µg 
ml-1 working solution for use in method with DDQ.  
Procedures 
CAA Method 
Different aliquots (0.20–4.0 ml) of a standard 500 
μg ml-1 RPG solution were accurately transferred into 
a series of 5 ml calibrated flasks and the total volume 
in each flask was brought to 4 ml by adding aceto-
nitrile. The content was mixed well after the addition 
of 1 ml of 0.2 % CAA solution and the absorbance 
was measured at 520 nm against a reagent blank si-
milarly prepared without the addition of RPG. 
DDQ Method 
Into a series of 5 ml calibrated flasks, different 
aliquots (0.25-4.0 ml) of a standard 100 μg ml-1 RPG 
solution were accurately transferred and the total vo-
lume were brought to 4 ml by adding adequate quan-
tity of acetonitrile. To each flask, 1 ml of 0.2% DDQ 
solution was added and mixed well. After 2 min, the 
absorbance of the red colored C-T complex was mea-
sured at 590 nm against the reference blank similarly 
prepared. 
Assay procedure for pharmaceutical formulation 
Twenty five tablets were weighed and pulve-
rized. An amount of tablet powder equivalent to 25 mg 
RPG was transferred into a 50 ml volumetric flask and 
about 30 ml of acetonitrile was added to the flask. The 
content was shaken well for 20 min and diluted to the 
mark with the same solvent. The resulting solution 
was filtered through Whatmann No. 42 filter paper 
and the filtrate was used for the assay by following 
the general procedure described under CAA method. 
The resulting tablet extract (500 μg ml-1 in RPG) was 
diluted to 100 μg ml-1 with acetonitrile and a suitable 
aliquot was used for the assay in DDQ method.  
Procedure for the analysis of placebo blank and 
synthetic mixture 
A placebo blank containing starch (10 mg), aca-
cia (15 mg), hydroxyl cellulose (10 mg), sodium cit-
rate (10 mg), talc (20 mg), magnesium stearate (15 
mg) and sodium alginate (10 mg) was made and its 
solution was prepared as described under “Assay 
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procedure for pharmaceutical formulation” and then 
subjected to analysis. A synthetic mixture was sepa-
rately prepared by adding pure RPG (25 mg) to the 
above mentioned placebo blank and the mixture was 
homogenized. The entire mixture containing 25 mg of 
RPG was taken and its extract was prepared as des-
cribed above. Aliquots of extracts containing three dif-
ferent concentrations of RPG were subjected to assay 
by following the general procedures and the percen-
tage recovery of RPG was evaluated. 
RESULTS AND DISCUSSION 
The chemistry involved in the proposed methods 
was based on the reaction of RPG as n-electron do-
nor with two π-acceptors, namely, CAA and DDQ to 
form charge transfer complexes which subsequently 
dissociate into radical anions depending on the pola-
rity of the solvent used [22]. In polar solvents, such as 
acetonitrile, complete electron transfer from the donor 
to the acceptor takes place with the formation of in-
tensely colored radical anions, according to the fol-
lowing equation: 
 
In CAA method, the reaction of RPG as n-elec-
tron donor with CAA as a π-acceptor results in the 
formation of an intense orange-red product which ex-
hibits absorption maxima at 520 nm in dioxane-aceto-
nitrile medium (Figure 1). This can be attributed to the 
formation of the corresponding CAA radical anion 
[23]. Similarly, in DDQ method, the interaction of RPG 
with DDQ in dioxane-acetonitrile at room temperature 
gave an intense reddish violet color which exhibit 
three maxima at 450, 550 and 590 nm due to the for-
mation of the DDQ radical anions [24]. The wave-
length 590 nm was selected for further studies be-
cause of higher sample absorbance and lower blank 
absorbance readings (Figure 2). 
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Figure 2. Absorption spectra of charge transfer complex of 
RPG-DDQ (50 μg ml-1 RPG): a) RPG-DDQ complex, 
b) DDQ in 1,4-dioxane. 
Optimization of reaction conditions 
Optimum conditions were established by mea-
suring the absorbance of C-T complexes at 520 and 
590 nm, for CAA and DDQ methods, respectively, by 
varying one parameter at a time and keeping others 
constant. The concentrations of RPG used in the opti-
mization studies are 200 μg ml-1 RPG and 50 μg ml-1 
RPG in CAA and DDQ methods, respectively. 
Effect of reagent concentration 
To establish optimum concentrations of the rea-
gents for the rapid formation of the stable charge-
transfer complexes, RPG was allowed to react with 
different volumes of the reagents (0.5-3.0 ml of 0.2% 
CAA or 0.5-3.0 ml of 0.2% DDQ). In both the cases, 
maximum and minimum absorbance values were ob-
tained for sample and blank, respectively, only when 
1 ml of the reagent was used. At higher volumes of 
reagents the greater absorbance for blank and lower 
absorbance for C-T complexes were observed. There-
fore, 1 ml of reagent in a total volume of 5 ml was 
used throughout the investigation. 
Effect of solvent to dissolve drug and reagents 
Acetonitrile was preferred to dissolve RPG than 
dichloromethane, acetone, 1,2-dichloroethane, 1,4-di-
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Figure 1. Absorption spectra of charge transfer complex of 
RPG-CAA (200 μg ml-1 RPG): a) RPG-CAA complex, 
b) CAA in 1,4-dioxane. 
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oxane, methanol or ethanol because the complex 
formed in these solvents had very low absorbance 
values. Whereas in the case of reagents, highly in-
tense colored products were formed when 1,4-di-
oxane medium was used as solvent to dissolve CAA 
and DDQ. Therefore, acetonitrile and 1,4-dioxane 
were chosen as solvents to dissolve RPG and the re-
agents, respectively. 
Effect of reaction time and stability of the 
C-T complexes 
The optimum reaction times were determined by 
measuring the absorbance of the formed complex 
upon the addition of reagent solution to RPG solution 
at room temperature. In both the methods the for-
mation of C-T complexation reaction was instanta-
neous and the absorbance values of RPG-CAA and 
RPG-DDQ complexes were stable for at least 5 h and 
75 min, respectively. 
Investigation of composition of C-T complexes 
The reaction stoichiometry between the drug 
and CAA or DDQ was determined spectrophotomet-
rically by applying mole ratio method [25]. The experi-
ments were performed by mixing a fixed volume of 
RPG (1.0 ml of 1.54×10-3 M RPG) with different vo-
lumes of each reagent separately (0.25-2.00 ml of 
1.54×10-3 M CAA or DDQ) and maintaining the total 
volume at 5.0 ml with acetonitrile. The plots obtained 
by the mole ratio method confirm the formation of 
RPG-CAA and RPG-DDQ complexes in a mole ratio 
of 1:1, where a break point at 1.0 was obtained (Fi-
gure 3). Even though the drug has two nitrogen 
atoms, only one nitrogen atom will be used in the for-
mation of C-T complexes, i.e., the nitrogen present in 
the piperidine ring, which is more basic than the nit-
rogen attached to the carbonyl group which is elec-
tron withdrawing group. Based on this, a possible re-
action pathway for the formation of C-T complex is 
proposed and shown in Scheme 1. 
Method validation 
Linearity, sensitivity, limits of detection and 
quantification 
A linear correlation was found between absor-
bance at λmax and concentration of RPG in the ranges 
given in Table 1. Regression analysis of the Beer’s 
law data using the method of least squares was made 
to evaluate the slope (b), intercept (a) and correlation 
coefficient (r) for each system and the values are pre-
sented in Table 1. The optical characteristics such as 
Beer’s law limits, molar absorptivity and Sandell’s 
sensitivity values for both the methods are also given 
in Table 1. The limits of detection (LOD) and quanti-
tation (LOQ) were calculated according to ICH guide-
lines [26] using the formulae:  
LOD = 3.3S/b and LOQ = 10S/b 
where b is the slope of the calibration plot and S is the 
standard deviation of “n” reagent blank determina-
tions under the same conditions as for the sample 
analysis in the absence of the analyte (RPG) (n = 5 
and 6 for CAA and DDQ methods, respectively). The 
calculated LOD and LOQ are also presented in Table 1. 
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Figure 3. Molar ratio plot for RPG-CAA/DDQ (1.54×10-3 M of RPG, CAA and DDQ) complexes. 
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Precision and accuracy 
The assays described under the construction of 
calibration curves were repeated seven times within 
the day to determine the intra-day precision and five 
times on different days to determine the inter-day 
precision of the methods. These assays were per-
formed at three levels of analyte. The results of this 
study are summarized in Table 2. The percentage re-
lative standard deviation (%RSD) values were 
≤1.51% (intra-day) and ≤2.34% (inter-day) indicating 
high precision of the methods. Accuracy was eva-
luated as percentage relative error (RE) between the 
measured mean concentrations and taken concentra-
tions for RPG. The percentage relative error was cal-
culated at each concentration and these results are 
also presented in Table 2. Percent relative error 
(%RE) values of ≤2.10% demonstrates the high accu-
racy of the proposed methods. 
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Scheme 1. Possible reaction pathway for the formation of C-T complex between RPG and CAA/DDQ in acetonitrile-1,4-dioxane medium. 
Table 1. Sensitivity and regression parameters 
Parameter CAA method DDQ method 
λmax / nm 520 590 
Color stability 5 h 75 min 
Linear range, μg ml-1 20-400  5-80 
Molar absorptivity (ε), L mol-1 cm-1 1.02 × 103 4.60 × 103 
Sandell sensitivitya, μg cm-2 0.4438 0.0984 
Limit of detection (LOD), μg ml-1 7.07 2.42 
Limit of quantification (LOQ), μg ml-1 21.43 7.33 
Regression equation, Yb 
Intercept (a) 0.0046 -0.0132 
Slope (b) 0.0022 0.0115 
Correlation coefficient (r) 0.9995 0.9998 
Standard deviation of a (Sa) 9.65×10
-3 5.07×10-3 
Standard deviation of b (Sb) 4.00×10
-5 1.10×10-4 
a
Limit of determination as the weight in μg per ml of solution, which corresponds to an absorbance A = 0.001 measured in a cuvette of cross-sectional area 
1 cm2 and l = 1 cm; bY = a + bX, where Y is the absorbance, X is concentration in μg/ml, a is intercept, b is slope 
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Selectivity 
The results obtained from placebo blank and 
synthetic mixture analyses revealed that the inactive 
ingredients used in the preparation did not interfere in 
the assay of active ingredient. The absorbance values 
obtained from the placebo blank solution were almost 
equal to the absorbance of the blank which revealed 
no interference from the excipients. To study the role 
of additives added to the tablets, 2 ml each of the 
synthetic mixture solution (180 and 60 μg ml-1 in RPG 
from CAA and DDQ methods, respectively) was as-
sayed (n = 5). The percentage recoveries of 96.7- 
–103.6 with %RSD values in the range 0.86–2.11 de-
monstrated the accuracy as well as the precision of 
the proposed methods and complement the findings 
of the placebo blank analysis with respect to selec-
tivity. 
Robustness and ruggedness 
The robustness of the methods was evaluated 
by making small incremental changes in the volume 
of reagent, and the effect of the changes was studied 
on the absorbance of the complex systems. The 
changes had negligible influence on the results as 
revealed by small intermediate precision values ex-
pressed as %RSD ≤ 0.69%. Method ruggedness was 
demonstrated having the analysis done by four ana-
lysts, and also by a single analyst performing analysis 
on four different instruments in the same laboratory. 
Intermediate precision values (%RSD) in both instan-
ces were in the range 0.23-1.86 indicating acceptable 
ruggedness. The results are presented in Table 3. 
Application 
The proposed methods were applied to the 
quantification of RPG in commercially available Eu-
repa-2 (2 mg) and Eurepa-1 (1 mg) tablets. The re-
sults obtained were compared with those obtained by 
a reference method [4] which involves the titration of 
the tablet extract in 1:6 (methanol:anhydrous acetic 
acid) with perchloric acid. Statistical analysis of the 
results did not detect any significant difference in the 
performance of the proposed methods and the refe-
rence method with respect to accuracy and precision 
as revealed by the Student’s t-value and variance ra-
tio F-value. The results of this study are given in 
Table 4. 
Recovery study 
To further assess the accuracy of the proposed 
methods, recovery experiment was performed by ap-
plying the standard-addition technique. The recovery 
was assessed by determining the agreement between 
the measured standard concentration and added 
known concentration to the sample. The test was 
done by spiking the pre-analyzed tablet powder with 
pure RPG at three different levels (50, 100 and 150 % 
of the content present in the tablet powder (taken) 
and the total was found by the proposed methods. 
Each test was repeated three times. From this test the 
percentage recovery values were found in the range 
Table 2. Evaluation of intra-day and inter-day accuracy and precision (%RE - percent relative error, %RSD - relative standard deviation, 
n = number of measurements) 
Method RPG taken, μg ml-1 
Intra-day accuracy and precision (n = 7) Inter-day accuracy and precision (n = 5) 
RPG found, μg ml-1 %RE %RSD RPG found, μg ml-1 %RE %RSD 
CAA 50 
100 
150 
49.56 
100.11 
151.22 
0.67 
1.52 
0.57 
1.51 
0.76 
1.29 
50.53 
100.6 
151.76 
1.05 
1.42 
1.45 
2.21 
1.61 
1.07 
DDQ 20 
40 
60 
20.23 
40.15 
60.54 
2.10 
0.91 
1.21 
0.90 
1.12 
1.50 
20.25 
39.18 
59.59 
1.14 
1.03 
0.15 
1.02 
2.34 
1.54 
        
Table 3. Method robustness and ruggedness expressed as intermediate precision (% RSD); the volumes of CAA or DDQ added were 
1.0±0.2 ml 
Method RPG taken, μg ml-1 
Robustness Ruggedness 
Volume of the reagent, ml Inter-analysts (%RSD) (n = 4) Inter-instruments (%RSD) (n = 4)
CAA 100 
200 
300 
0.51 
0.69 
0.52 
0.23 
0.48 
0.27 
1.18 
1.86 
1.15 
DDQ 20 
40 
60 
0.39 
0.61 
0.45 
0.67 
0.64 
0.78 
1.06 
1.11 
1.39 
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of 98.24-104.0% with standard deviation values from 
1.08-3.35%. Closeness of the results to 100% showed 
the fairly good accuracy of the methods. These re-
sults are shown in Table 5. 
CONCLUSIONS 
Unlike the chromatographic and voltammetric 
methods, the proposed methods are simple and cost 
effective. The importance lies in the reactions upon 
which the procedures are based rather than the so-
phistication of the instrument. The proposed methods 
are superior to the existing UV-spectrophotometric 
methods in terms of selectivity as the interferences 
from many excipients present in the formulations will 
increases in the UV region compared with visible re-
gion. Also, all reported visible spectrophotometric me-
thods are based on extractive spectrophotometric 
technique which has some difficulties and inaccu-
racies due to incomplete extraction or the formation of 
emulsions between the hydrocarbon solvent and the 
basic compound-containing solution. In addition, ex-
tractive spectrophotometric procedures are time con-
suming and required rigid pH control. The reagents 
used in the proposed methods are cheaper, easily 
available and the procedures do not involve any cri-
tical reaction conditions or tedious sample prepa-
ration. The results are unaffected by slight variations 
in the optimized conditions such as reagent volume. 
Among the proposed methods, DDQ method was 
more sensitive than CAA method as can be seen from 
the molar absorptivity values. The methods are accu-
rate and adequately sensitive and free from interfe-
rence by common tablet additives and excipients. 
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RPG in tablet
μg ml-1 
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Total found 
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recovereda 
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NAUČNI RAD 
  SPEKTROFOTOMETRIJSKO ODREĐIVANJE 
REPAGLINIDA U TABLETAMA ZASNOVANE NA 
REAKCIJI FORMIRANJA KOMPLEKSA UZ IZMENU 
NAELEKTRISANJA SA HLORANILNOM KISELINOM 
I DIHLORO-DICIJANO BENZOHINONA 
Razvijene su dve jednostavne, tačne, precizne, jeftine, selektivne i osetljive spektrofoto-
metrijske metode za određivanje repaglinida (RPG) u rasutom stanju i tabletama. Meto-
de su zasnovane na reakciji formiranja kompleksa uz izmenu naelektrisanja između 
RPG u acetonitrilu sa p-hloranilnom kiselinom (CAA) ili 2,3-dihloro-5,6-diciano-1,4-ben-
zokuinone (DDQ) u dioksanu pri čemu se grade intenzivno obojeni anjoni čiji se intenzi-
teti mere na 520 (CAA) ili 590 nm (DDQ). Optimizovani su eksperimentalni uslovi koji 
utiču na formiranje kompleksa, stabilnost obojenih jedinjenja i osetljivost reakcije. Nađe-
no je da pod optimalnim uslovima za reakcije RPG sa CAA i DDQ važi Berov zakon u 
opsegu koncentracija 20-400 i 5-80 µg ml-1, odgovarajući koeficijenti korelacije su 0,9995 
i 0,9998, molarne apsortivnosti kompleksa su 1,02×103 i  4.60×103 L mol-1 cm-1, odgova-
rajući Sandelovi indeksi su 0,4438 i 0,0984 µg cm-2, limiti detekcije (LOD) su 7,07 i 2,42 
µg ml-1 i limiti kvantifikacije (LOQ) su 21,43 i 7,33 µg ml-1. Validacioni rezultati su pokaza-
li da je tačnost određivanja u toku jednog i više dana iznad 97,56%. Preciznost određi-
vaja ne prelazi 2,5% RSD. Metode su uspešno primenjene za određivanje RPG u obliku 
tableta, a rezultati su u dobroj saglasnosti sa vrednostima koje su propisane za lek što je 
pokazano i sa „recovery“ vrednostima koje su bile u rasponu od 99,22-102,8%, sa stan-
dardnom devijacijom vrednosti manjom od 2%. Tačnost metode je potvrđena metodom 
standardnog dodatka sa odličnim „recovery“ vrednostima koje su u opsegu 98,24-
–104,0±1.08-3.35. 
Ključne reči: repaglinid; p-hloranilna kiselina; 2,3-dihloro-5,6-dicijano-1,4-benzo-
hinon; kompleksiranje uz izmenu naelektrisanja; farmaceutski preparati. 
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